|
Back
The Efficacy of Distant
Healing:
An Ongoing Four-Armed Randomized
Study in Europe (EUHEALS)
Principal
Investigators: H. Walach1, PhD; H. Bösch 1, Dipl. Psych.; E.
Haraldsson 2, PhD; A. Marx 3, MD; H. Tomasson 4; G. Lewith, PhD 5
Affiliations: 1
Institute of Environmental Medicine and Hospital Epidemiology, University
Hospital Freiburg; 2 Department of Psychology, University of Reykjavik,
Iceland; 3 Institute of Clinical Epidemiology, University Hospital Basel,
Switzerland; 4 Faculty of Economics & Business Administration, University
of Reykjavik, Iceland; 5 Community Clinical Sciences, University of
Southampton Medical School, UK
Background:
Preliminary evidence suggests possible effects during distant healing. In
this study, patients suffering from multiple chemical sensitivity and
chronic fatigue syndrome, which have few effective treatment options, will
be offered distant healing within a formal trial.
Objective of the study: The question posed
is two-fold: (1) Do patients with chronic fatigue (SICF, CFS) or multiple
chemical sensitivity (SR-MCS) benefit from distant healing? Is there a
general, non-specific effect of healing due to expectation of healing? (2)
Do patients who know that they are being treated benefit more than those
who dont? Is there a specific effect of healing, apart from the
nonspecific effect of expectation?
Method: This four-armed randomized trial
will include 400 patients with self-attributed, environmental problems
within the diagnostic criteria of Severe Idiopathic Chronic Fatigue,
Chronic Fatigue Syndrome or Multiple Chemical Sensitivity. Patients will
be recruited by specialized general practitioners and environmental
clinics. They will be treated by healers distributed all over Europe,
coming from various healing traditions and nationalities. Each patient
will be treated by three healers. Healers will have no contact with the
patients and will only be provided with the patients first name and a
photograph. The patients will be randomized to one of four groups in a 2*2
factorial design. They will either receive (distant) healing or not, and
either know or not know this decision. Primary outcome measure will be the
mental health summary scale of the MOS SF-36. The measure will be taken at
the beginning and at the end of a 6 month treatment or waiting period
respectively.
Hypotheses: Open treatment will be more
effective than blind treatment, i.e. an interaction between treatment and
knowledge of treatment is expected. Open waiting will be less effective
than blind waiting, i.e. an interaction between no-treatment and knowledge
of treatment is to be expected.
Relationship to SIIB Mission and Focus on Healing:
Few large-scale clinical studies, particularly with control groups, have
investigated distant healing to date. This study will be able to evaluate
if distant healing works and to what extents knowledge and expectation of
healing influences that effect.
|